Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dent

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
The Journal of Experimental Medicine|June 5, 2002
Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthmaJoerg Mattes, Ming Yang, Surendran Mahalingam, et al.
Leukemia Research|June 10, 2009
Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control studyCindy M Chang, Jane C Schroeder, Wen-Yi Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2024
Ipatasertib plus Paclitaxel for Patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III TrialRebecca A Dent, Sung-Bae Kim, Mafalda Oliveira, et al.
Journal of Clinical Epidemiology|March 25, 2014
Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patientsYin Ting Cheung, Yu Lee Foo, Maung Shwe, et al.
JCO Oncology Practice|January 13, 2021
Early Outcomes of a National Cancer Center's Strategy Against COVID-19 Executed Through a Disease Outbreak Response TaskforceJin Wei Kwek, Jack J Chan, Ravindran Kanesvaran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2019
Inflammasome-Independent Role for NLRP3 in Controlling Innate Antihelminth Immunity and Tissue Repair in the LungAlistair L Chenery, Rafid Alhallaf, Zainab Agha, et al.
Blood Advances|April 27, 2022
Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider supportAlfred Ian Lee, Leah E Masselink, Laura M De Castro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort studyY T Cheung, T Ng, M Shwe, et al.
Haematologica|June 22, 2019
Microhomology-mediated end joining drives complex rearrangements and overexpression of <i>MYC</i> and <i>PVT1</i> in multiple myelomaAneta Mikulasova, Cody Ashby, Ruslana G Tytarenko, et al.
BMC Cancer|April 25, 2018
Cost of Medical Care of Patients with Advanced Serious Illness in Singapore (COMPASS): prospective cohort study protocolIrene Teo, Ratna Singh, Chetna Malhotra, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
The Journal of Experimental Medicine|June 5, 2002
Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthmaJoerg Mattes, Ming Yang, Surendran Mahalingam, et al.
Leukemia Research|June 10, 2009
Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control studyCindy M Chang, Jane C Schroeder, Wen-Yi Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2024
Ipatasertib plus Paclitaxel for Patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III TrialRebecca A Dent, Sung-Bae Kim, Mafalda Oliveira, et al.
Journal of Clinical Epidemiology|March 25, 2014
Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: cognitive function (FACT-Cog) in breast cancer patientsYin Ting Cheung, Yu Lee Foo, Maung Shwe, et al.
JCO Oncology Practice|January 13, 2021
Early Outcomes of a National Cancer Center's Strategy Against COVID-19 Executed Through a Disease Outbreak Response TaskforceJin Wei Kwek, Jack J Chan, Ravindran Kanesvaran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2019
Inflammasome-Independent Role for NLRP3 in Controlling Innate Antihelminth Immunity and Tissue Repair in the LungAlistair L Chenery, Rafid Alhallaf, Zainab Agha, et al.
Blood Advances|April 27, 2022
Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider supportAlfred Ian Lee, Leah E Masselink, Laura M De Castro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2015
Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort studyY T Cheung, T Ng, M Shwe, et al.
Haematologica|June 22, 2019
Microhomology-mediated end joining drives complex rearrangements and overexpression of <i>MYC</i> and <i>PVT1</i> in multiple myelomaAneta Mikulasova, Cody Ashby, Ruslana G Tytarenko, et al.
BMC Cancer|April 25, 2018
Cost of Medical Care of Patients with Advanced Serious Illness in Singapore (COMPASS): prospective cohort study protocolIrene Teo, Ratna Singh, Chetna Malhotra, et al.
Pageof 25